NYSE$DOC
Healthpeak Properties Inc · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Reported results for the third quarter ended September 30, 2023.
Healthpeak Properties reported third-quarter results, featuring a net income of $0.12 per share, Nareit FFO of $0.46 per share, FFO as Adjusted of $0.45 per share, and AFFO of $0.40 per share. The company experienced a blended Total Same-Store Portfolio Cash (Adjusted) NOI growth of 6.0%.
- Net income was $0.12 per share.
- Nareit FFO was $0.46 per share.
- FFO as Adjusted was $0.45 per share.
- Blended Total Same-Store Portfolio Cash (Adjusted) NOI growth was 6.0%.
Headline financials
Revenue & EPS history
Healthpeak · Revenue · Quarterly
$556M
Revenue by segment
Healthpeak · $582M total across 3 segments · Q1 2020
- Rental and related revenues$315M—54.1%
- Resident fees and services$264M—45.3%
- Interest income and other$3.69M—0.6%
Forward guidance
Healthpeak updated its full year 2023 guidance, increasing the diluted earnings per common share to a range of $0.53 - $0.55 and the midpoint of 2023 FFO as Adjusted guidance by $0.02 per share. Total Portfolio Same-Store Cash (Adjusted) NOI growth guidance was also increased by 75 basis points at the midpoint.
Tailwinds
- Diluted earnings per common share guidance increased to $0.53 – $0.55.
- Diluted Nareit FFO per share guidance increased to $1.76 – $1.78.
- Diluted FFO as Adjusted per share guidance increased to $1.76 – $1.78.
- Total Portfolio Same-Store Cash (Adjusted) NOI growth guidance increased to 4.25% – 5.25%.
- Estimates are based on existing market conditions, transaction timing, and other assumptions for the year ending December 31, 2023.
Headwinds
- Estimates do not reflect the potential impact from unannounced future transactions.
- Guidance is subject to risks and uncertainties, including macroeconomic trends, tenant financial conditions, and regulatory changes.
- Illiquidity of real estate investments.
- Property development, redevelopment, and tenant improvement activity risks.
- Changes within the industries in which Healthpeak operates.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2023
-0.9%
Avg return
Earnings day
-0.7%
Avg return
5 days after
+0.1%
Avg return
30 days after
40%
29 / 72 earnings
Positive
+5.8%
Q3 2020
Best reaction
-8.1%
Q4 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.1% | +17.3% | +19.9% | |
| Q4 2025 | +0.0% | -0.4% | +2.9% | |
| Q3 2025 | +1.2% | -5.2% | -3.8% | |
| Q2 2025 | +1.6% | +1.1% | +6.1% | |
| Q1 2025 | -5.2% | -5.2% | -10.5% | |
| Q4 2024 | -1.6% | -2.6% | -1.2% | |
| Q3 2024 | -3.6% | -2.6% | -6.5% | |
| Q2 2024 | -0.1% | -1.4% | +1.3% | |
| Q1 2024 | +0.9% | -0.1% | +2.5% | |
| Q4 2023 | -0.8% | -4.4% | +3.7% | |
| Q3 2023 | -5.3% | +4.8% | +4.4% | |
| Q2 2023 | -2.2% | -2.3% | -8.9% | |
| Q1 2023 | +5.8% | +2.0% | -6.3% | |
| Q4 2022 | -2.1% | -5.0% | -18.3% | |
| Q3 2022 | -0.3% | +1.2% | +10.2% | |
| Q2 2022 | -2.2% | -3.8% | -4.6% | |
| Q1 2022 | +0.2% | -4.9% | -9.1% | |
| Q4 2021 | -2.8% | -2.3% | +7.8% | |
| Q3 2021 | -1.8% | -3.8% | -5.8% | |
| Q2 2021 | +0.8% | -0.8% | -0.1% | |
| Q1 2021 | -3.1% | -1.8% | -0.8% | |
| Q4 2020 | -7.1% | -4.9% | +2.4% | |
| Q3 2020 | +5.8% | +4.1% | +9.4% | |
| Q2 2020 | +1.1% | +6.4% | +5.7% | |
| Q1 2020 | -4.4% | -3.5% | +10.5% | |
| Q4 2019 | -8.1% | -7.9% | -29.8% | |
| Q3 2019 | -2.2% | -6.6% | -4.0% | |
| Q2 2019 | +4.4% | +2.9% | +8.5% | |
| Q1 2019 | +2.6% | +1.7% | +6.5% | |
| Q4 2018 | -0.5% | -1.0% | +1.2% | |
| Q3 2018 | +0.3% | +2.1% | +4.0% | |
| Q2 2018 | +1.8% | +1.8% | +4.0% | |
| Q1 2018 | +1.1% | +1.5% | +3.4% | |
| Q4 2017 | +0.8% | +2.3% | +6.8% | |
| Q3 2017 | -0.4% | +0.1% | -1.1% | |
| Q2 2017 | -0.6% | -1.4% | +0.4% | |
| Q1 2017 | -4.4% | -3.6% | +2.0% | |
| Q4 2016 | +1.9% | +0.2% | -4.7% | |
| Q3 2016 | -5.9% | -0.7% | -4.6% | |
| Q2 2016 | -1.2% | -1.3% | +0.3% | |
| Q1 2016 | -2.3% | — | — | |
| Q4 2015 | +2.8% | — | — | |
| Q3 2015 | -7.7% | — | — | |
| Q2 2015 | -0.3% | — | — | |
| Q1 2015 | +1.6% | — | — | |
| Q4 2014 | -0.7% | — | — | |
| Q3 2014 | +1.3% | — | — | |
| Q2 2014 | +2.5% | — | — | |
| Q1 2014 | +1.0% | — | — | |
| Q4 2013 | +2.0% | — | — | |
| Q3 2013 | -0.8% | — | — | |
| Q2 2013 | -2.7% | — | — | |
| Q1 2013 | +0.5% | — | — | |
| Q4 2012 | +0.7% | — | — | |
| Q3 2012 | +0.7% | — | — | |
| Q2 2012 | -0.4% | — | — | |
| Q1 2012 | +0.8% | — | — | |
| Q4 2010 | -3.8% | — | — | |
| Q4 2011 | -3.8% | — | — | |
| Q3 2011 | -3.7% | — | — | |
| Q2 2011 | -0.5% | — | — | |
| Q1 2011 | -0.2% | — | — | |
| Q3 2010 | -0.9% | — | — | |
| Q2 2010 | -0.9% | — | — | |
| Q1 2009 | -4.1% | — | — | |
| Q1 2010 | -0.5% | — | — | |
| Q4 2007 | +3.2% | — | — | |
| Q3 2008 | -5.2% | — | — | |
| Q3 2009 | -5.2% | — | — | |
| Q2 2008 | +0.6% | — | — | |
| Q2 2009 | +0.6% | — | — | |
| Q4 2008 | +0.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro